- Home
- Publications
- Publication Search
- Publication Details
Title
The solid progress of nanomedicine
Authors
Keywords
-
Journal
Drug Delivery and Translational Research
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-06
DOI
10.1007/s13346-020-00743-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- U.S. cancer institute cancels nanotech research centers
- (2019) Robert Service SCIENCE
- Have nanomedicines progressed as much as we’d hoped for in drug discovery and development?
- (2019) Bruno Sarmento Expert Opinion on Drug Discovery
- The beginning of the end of the nanomedicine hype
- (2019) Kinam Park JOURNAL OF CONTROLLED RELEASE
- On the issue of transparency and reproducibility in nanomedicine
- (2019) Hon S. Leong et al. Nature Nanotechnology
- Challenges in the implementation of MIRIBEL criteria on nanobiomed manuscripts
- (2019) Helena F. Florindo et al. Nature Nanotechnology
- NCI Centers of Cancer Nanotechnology Excellence (CCNEs) – A full story to set the record straight
- (2019) Piotr Grodzinski JOURNAL OF CONTROLLED RELEASE
- Nanomedicine: From where are we coming and where are we going?
- (2019) Patrick Couvreur JOURNAL OF CONTROLLED RELEASE
- Smart cancer nanomedicine
- (2019) Roy van der Meel et al. Nature Nanotechnology
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy
- (2018) Bijun Zeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement
- (2018) Jingjing Liu et al. Nano Today
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
- (2018) Fred C. Lam et al. Nature Communications
- Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
- (2018) Denzil Furtado et al. ADVANCED MATERIALS
- From Design to the Clinic: Practical Guidelines for Translating Cardiovascular Nanomedicine
- (2018) Iwona Cicha et al. CARDIOVASCULAR RESEARCH
- Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
- (2018) Fatemeh Farjadian et al. Nanomedicine
- Nano Tools Pave the Way to New Solutions in Infectious Disease
- (2017) Paula T. Hammond ACS Infectious Diseases
- Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
- (2016) Michael Untch et al. LANCET ONCOLOGY
- Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
- (2016) Susan Ashton et al. Science Translational Medicine
- Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction
- (2015) Marjan Gharagozloo et al. Nanomedicine-Nanotechnology Biology and Medicine
- α-Enolase–binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer
- (2015) Chien-Hsun Wu et al. Science Translational Medicine
- A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models
- (2015) Jayanta Bhattacharyya et al. Nature Communications
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
- (2013) S. Eliasof et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started